| 609418 |
NEURO-ONCOLOGY |
EXTH-16. TREATMENT OF THREE DIFFERENT BRAF-V600E POSITIVE BRAIN TUMORS WITH VEMURAFENIB AND DABRAFENIB/TRAMETINIB: A CASE SERIES | EXTH-16. TREATMENT OF THREE DIFFERENT BRAF-V600E POSITIVE BRAIN TUMORS WITH VEMURAFENIB AND DABRAFENIB/TRAMETINIB: A CASE SE |
2020-11-01 |
10.1093/neuonc/noaa215.370 |
Dhir Nikita, Chandrahas Sheila, O’Suoji Chibuzo, Al-Rahawan Mohamad |
| 609417 |
NEURO-ONCOLOGY |
CTNI-07. DELIVERY AND ACTIVITY OF SN-38 BY SACITUZUMAB GOVITECAN IN CNS TUMORS | CTNI-07. DELIVERY AND ACTIVITY OF SN-38 BY SACITUZUMAB GOVITECAN IN CNS TUMORS |
2020-11-01 |
10.1093/neuonc/noaa215.174 |
Brenner Andrew, Floyd John, Pandey Renu, Chiou Jennifer, Surapreneni Prathiba, Kaklamani Virginia, lathrop Kate, Crownover Richard, Caron Jean Louis, Tiziani Stefano |
| 609416 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
480 Preliminary evaluation of a novel coronavirus vaccine (CORVax) using electroporation of plasmid DNA encoding a stabilized prefusion SARS-CoV-2 spike protein alone or with transfection of plasmid IL-12 |
2020-11-01 |
10.1136/jitc-2020-sitc2020.0480 |
Jensen Shawn, Twitty Christopher, Paustian Christopher, Laws Madelein, McDonnell Glenna, Wegmann Keith, Moudgil Tarsem, Afentoulis Michael, Han Mia, Foerter Kellie Malloy, Canton David, Lee Jack, Nguyen Bianca, Rodriguez John, Jaffe Kim, Piening Brian, Bifulco Carlo, O’Connor Daniel, Urba Walter, Leidner Rom, Hilton Traci, Hu Hong-Ming, Fox Bernard |
| 609415 |
INDIAN HEART JOURNAL : OFFICIAL PUBLICATION OF THE CARDIOLOGICAL SOCIETY OF INDIA |
Prevalence and correlates of metabolic syndrome among rural women in Mysore, India |
2020-11-01 |
10.1016/j.ihj.2020.09.015 |
Krupp Karl, Adsul Prajakta, Wilcox Meredith L., Srinivas Vijaya, Frank Elizabeth, Srinivas Arun, Madhivanan Purnima |
| 609414 |
INDIAN HEART JOURNAL : OFFICIAL PUBLICATION OF THE CARDIOLOGICAL SOCIETY OF INDIA |
Comparison of HBA1C in diabetic patients in cardiovascular diseases |
2020-11-01 |
10.1016/j.ihj.2020.11.098 |
Palta Rohit, Choudhary Shachindra, Thakur Dhanakar |
| 609413 |
BMJ OPEN |
Patient needs and priorities for patient navigator programmes in chronic kidney disease: a workshop report |
2020-11-01 |
10.1136/bmjopen-2020-040617 |
Guha Chandana, Lopez-Vargas P, Ju Angela, Gutman Talia, Scholes-Robertson Nicole Jane, Baumgart Amanda, Wong Germaine, Craig Jonathan, Usherwood Tim, Reid Sharon, Cullen Vanessa, Howell Martin, Khalid Rabia, Teixeira-Pinto Armando, Wyburn Kate, Sen Shaundeep, Smolonogov Tanya, Lee Vincent W, Rangan Gopala K, Matus Gonzales Andrea, Tong Allison |
| 609412 |
NEURO-ONCOLOGY |
EPID-03. SINGLE INSTITUTIONAL CLINICAL AND GENETIC ANALYSIS OF METASTATIC PROSTATE CANCER WITH AND WITHOUT BRAIN METASTASES | EPID-03. SINGLE INSTITUTIONAL CLINICAL AND GENETIC ANALYSIS OF METASTATIC PROSTATE CANCER WITH AND WITHOUT BRAIN METASTASES |
2020-11-01 |
10.1093/neuonc/noaa215.321 |
Jaeger Ellen, Jang Albert, Xie John, Barata Pedro, Ledet Elisa, Trevino Christopher |
| 609411 |
NEURO-ONCOLOGY |
QOLP-26. USE OF MEDICAL ASSISTANCE IN DYING (“DEATH WITH DIGNITY”) IN WASHINGTON STATE PATIENTS WITH BRAIN TUMORS. | QOLP-26. USE OF MEDICAL ASSISTANCE IN DYING (“DEATH WITH DIGNITY”) IN WASHINGTON STATE PATIENTS WITH BRAIN TUMORS. |
2020-11-01 |
10.1093/neuonc/noaa215.751 |
Graber Jerome, Sofie Kaite, Taylor Lynne |
| 609410 |
NEURO-ONCOLOGY |
QOLP-01. OUTCOME ASSESSMENT OF MULTIDISCIPLINARY BRAIN TUMOR BOARD MEETING RECOMMENDATIONS FOR BRAIN METASTASIS: IS THERE A GAP? | QOLP-01. OUTCOME ASSESSMENT OF MULTIDISCIPLINARY BRAIN TUMOR BOARD MEETING RECOMMENDATIONS FOR BRAIN METASTASIS: IS THERE A |
2020-11-01 |
10.1093/neuonc/noaa215.726 |
Santos-Pinheiro Fernando, Bovi Joseph, Peltier Wendy, Connelly Jennifer, Mueller Wade, Straza Michael, Puckett Lindsay, Crabb Marianne, Leuck Julianne, Zwagerman Nathan, Thompson Jonathan, Schultz Christopher, Lindstedt Jennifer, Roller-Voigt Kimberly, Nelson Ariel, Bichler Sarah, Leutenegger Alexandra, Erlitz Tracy, Brausch Carolyn, Saeed Hina, Hahn Dustin, Santos-Pinheiro Fernando |
| 609409 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
373 Phase 1/2 study of subcutaneously administered ALKS 4230, a novel engineered cytokine, as monotherapy and in combination with pembrolizumab, in patients with advanced solid tumors: ARTISTRY-2 |
2020-11-01 |
10.1136/jitc-2020-sitc2020.0373 |
Powderly John, Carthon Bradley, Ernstoff Marc, Olszanski Anthony, Wrangle John, Shields Anthony, Piha-Paul Sarina, Curtis Kelly, Bidollari Ilda, Du Yangchun, Sun Lei, Putiri Emily, Wang Yan, Losey Heather, Dezube Bruce, Dezube Bruce, Vaishampayan Ulka |
